Solid Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Solid Biosciences

10/11/2022 14:10

* Solid Biosciences Inc  SLDB.OQ  reported a quarterly
adjusted
loss of $2.71​​ per share for the quarter ended in September.
The mean expectation of five analysts for the quarter was for a
loss of $2.67 per share.
    * Reported revenue was zero​; analysts expected $1.18
million. 
    * Solid Biosciences Inc's reported EPS for the quarter was a
loss
of $2.71​.
    * The mean earnings estimate of analysts had risen by
about 6.3%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Solid Biosciences Inc shares had fallen by 9.1% this
quarter and
lost 75.8% so far this year.
    * The company reported a quarterly loss of $20.41 million.
    * Wall Street's median 12-month price target for Solid
Biosciences
Inc is $30.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
10 at 02:10 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -2.67          -2.71          Missed
 Jun. 30 2022      -3.15          -3.30          Missed
 Mar. 31 2022      -2.76          -3.30          Missed
 Dec. 31 2021      -2.91          -2.40          Beat